0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Two thirds of all deaths in patients with type 2 diabetes (T2D) are from cardiovascular disease, making risk management crucial1. In this lecture, Cardiologist Prof Andrew Sindone and Endocrinologist Dr Ted Wu discuss the importance of SGLT2 inhibitors and the ground-breaking evidence that has seen this class of drugs now PBS-listed alongside metformin for all T2D patients with CVD, high CV risk or First Nations Australians, with no longer any HbA1c requirement2. This recognises the significant cardiovascular benefits the class offers T2D patients.
1 Low Wang, CC, et al. Circulation 2016 Jun 14;133(24):2459-502.
2 Pharmaceutical Benefits Scheme. Available at: www.pbs.gov.au. Accessed May 2025.
Browse the latest videos from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
